New schizophrenia pill aims to ease severe symptoms in hospitalized patients
NCT ID NCT07105098
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 28 times
Summary
This study tests an experimental drug called NBI-1117568 to see if it can improve schizophrenia symptoms like hallucinations and confusion in adults who need hospital care. About 284 participants will receive either the drug or a placebo for 5 weeks while staying in the hospital. The main goal is to measure symptom changes using a standard rating scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Neurocrine Clinical Site
RECRUITINGCulver City, California, 90230, United States
-
Neurocrine Clinical Site
RECRUITINGGarden Grove, California, 92845, United States
-
Neurocrine Clinical Site
RECRUITINGRiverside, California, 92506, United States
-
Neurocrine Clinical Site
RECRUITINGAtlanta, Georgia, 30328, United States
-
Neurocrine Clinical Site
RECRUITINGNorth Canton, Ohio, 44720, United States
-
Neurocrine Clinical Site
RECRUITINGSliven, 8800, Bulgaria
-
Neurocrine Clinical Site
WITHDRAWNVeliko Tarnovo, 5047, Bulgaria
-
Neurocrine Clinical Site
RECRUITINGVratsa, 3001, Bulgaria
-
Neurocrine Clinical Site
RECRUITINGGyőr, 9024, Hungary
-
Neurocrine Clinical Site
RECRUITINGBrasov, 500123, Romania
-
Neurocrine Clinical Site
RECRUITINGBrasov, 507190, Romania
-
Neurocrine Clinical Site
RECRUITINGBucharest, 41914, Romania
-
Neurocrine Clinical Site
RECRUITINGBelgrade, 11000, Serbia
-
Neurocrine Clinical Site
RECRUITINGGornja Toponica, 18202, Serbia
-
Neurocrine Clinical Site
RECRUITINGKragujevac, 34000, Serbia
Conditions
Explore the condition pages connected to this study.